Scholarlink

Abstract <p>Parkinson’s disease (PD) and multiple system atrophy (MSA) are neurodegenerative diseases characterized by the alpha-synuclein protein pathology, which may be associated with a changed expression of the <i>SNCA</i> gene encoding this protein. We studied the expression of four <i>SNCA</i> transcript variants, encoding the protein isoforms SNCA-140, SNCA-126, SNCA-112, and SNCA-98, in blood leukocytes of 86 PD and 52 MSA patients compared to 50 control subjects without neurological pathology. All <i>SNCA</i> transcript variants were increased in leukocytes in MSA patients (predominantly alternatively spliced short transcripts), especially with parkinsonian type of disease. No significant <i>SNCA</i> expression changes were found in the group of PD patients. The results obtained emphasize the differences in the pathogenesis of these two synucleinopathies—PD and MSA.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Differential Level of Transcripts of Alpha-Synuclein in Blood of Patients with Parkinson’s Disease and Multiple System Atrophy

  • 期刊论文

  • 发表日期：

    2026年3月16日

查看全文
  • L. S. Karan,
  • N. Yu. Abramycheva,
  • I. V. Minaev,
  • T. A. Krutyakova,
  • A. O. Protopopova,
  • A. R. Protsenko,
  • I. A. Berdalina,
  • E. Yu. Fedotova,
  • S. N. Illarioshkin

摘要

Abstract

Parkinson’s disease (PD) and multiple system atrophy (MSA) are neurodegenerative diseases characterized by the alpha-synuclein protein pathology, which may be associated with a changed expression of the SNCA gene encoding this protein. We studied the expression of four SNCA transcript variants, encoding the protein isoforms SNCA-140, SNCA-126, SNCA-112, and SNCA-98, in blood leukocytes of 86 PD and 52 MSA patients compared to 50 control subjects without neurological pathology. All SNCA transcript variants were increased in leukocytes in MSA patients (predominantly alternatively spliced short transcripts), especially with parkinsonian type of disease. No significant SNCA expression changes were found in the group of PD patients. The results obtained emphasize the differences in the pathogenesis of these two synucleinopathies—PD and MSA.